Related Experiment Video
Updated: Mar 8, 2026

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
Published on: February 16, 2024
Gastrin and Gastric Cancer
Helge L Waldum1, Liv Sagatun1, Patricia Mjønes2
1Department of Gastroenterology and Hepatology, St Olav's Hospital, Trondheim, Norway; Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
Helicobacter pylori (Hp) infection is a primary cause of gastric cancer. Research explores how Hp infection leads to atrophic gastritis and gastric cancer, highlighting gastrin's role.
Area of Science:
- Gastroenterology
- Oncology
- Microbiology
Background:
- Gastric cancer, though less frequent, remains significant due to poor prognosis in Western countries.
- Reduced Helicobacter pylori (Hp) prevalence may explain the decline in gastric cancer incidence.
- Lauren's classification distinguishes intestinal and diffuse gastric carcinoma types with different epidemiology.
Purpose of the Study:
- Investigate the mechanisms by which Hp infection causes gastric cancer.
- Clarify the role of gastrin and enterochromaffin-like cells in gastric carcinogenesis.
- Assess the implications of long-term acid secretion inhibitor use.
Main Methods:
- Review of scientific literature on Hp infection and gastric cancer.
- Analysis of pathological classifications and epidemiological data.
- Examination of the relationship between atrophic gastritis, hypoacidity, and hypergastrinemia.
Main Results:
- Atrophic gastritis of oxyntic mucosa is a key precursor to gastric cancer, potentially via hypoacidity and hypergastrinemia.
- Gastrin and its target enterochromaffin-like cells appear crucial in gastric carcinogenesis.
- Long-term acid secretion inhibition can induce secondary hypergastrinemia.
Conclusions:
- Hp infection is the principal etiological factor for gastric cancer.
- Gastrin plays a significant role in the development of gastric cancer.
- Caution is advised regarding long-term acid suppression therapy due to induced hypergastrinemia.
More Related Videos
Related Concept Videos
Gastritis-I: Introduction and Types
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Hormones Secreted by the Stomach
Each of these hormones secreted by different enteroendocrine cells plays a unique role in digestion. Here are a few examples:
Mucosal Barrier of the Stomach
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...

